Both the British Inherited Metabolic Disease Group (BIMDG) and the Royal College of Paediatrics and Child Health (RCPCH) have issued guidance on how clinically extremely vulnerable (CEV) adults and children will be assessed during this current lockdown.
We have gathered together some information and guidance that you may find helpful.
BIMDG | Guidance for identifying individuals with inherited metabolic disease (IMD) vulnerable to COVID-19 complications (published November 2020)
BIMDG | News page for IMD and Coronavirus (COVID-19)
BIMDG | COVID-19 resources